NASDAQ:STAA - STAAR Surgical Stock Price, Forecast & News

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings results on Wednesday, October, 30th. The medical instruments supplier reported $0.05 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.05. The medical instruments supplier earned $39.06 million during the quarter, compared to the consensus estimate of $37.50 million. STAAR Surgical had a return on equity of 13.84% and a net margin of 6.15%. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for STAAR Surgical.

STAAR Surgical will be holding an earnings conference call on Wednesday, February 26th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

STAAR Surgical updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $150.2-150.2 million, compared to the consensus revenue estimate of $149.45 million.

3 Wall Street analysts have issued 1 year price objectives for STAAR Surgical's shares. Their forecasts range from $45.00 to $56.00. On average, they anticipate STAAR Surgical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 61.0% from the stock's current price. View Analyst Price Targets for STAAR Surgical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

Press coverage about STAA stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. STAAR Surgical earned a daily sentiment score of 1.2 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for STAAR Surgical.

STAAR Surgical saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 4,250,000 shares, an increase of 7.6% from the January 15th total of 3,950,000 shares. Based on an average trading volume of 393,400 shares, the short-interest ratio is currently 10.8 days. Currently, 9.7% of the shares of the stock are short sold. View STAAR Surgical's Current Options Chain.

Some companies that are related to STAAR Surgical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include NVIDIA (NVDA), Rockwell Medical (RMTI), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Vanda Pharmaceuticals (VNDA), Agile Therapeutics (AGRX), Amarin (AMRN), Immunomedics (IMMU), Karyopharm Therapeutics (KPTI) and TG Therapeutics (TGTX).

STAAR Surgical's stock is owned by many different of retail and institutional investors. Top institutional investors include Palo Alto Investors LP (8.48%), Baillie Gifford & Co. (4.36%), Capital International Investors (4.12%), State Street Corp (2.56%), Janus Henderson Group PLC (1.98%) and Defender Capital LLC. (1.35%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Barclays PLC, Palo Alto Investors LP, State Street Corp, BosValen Asset Management Ltd, Principal Financial Group Inc., King Luther Capital Management Corp and Chicago Equity Partners LLC. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes. View Insider Buying and Selling for STAAR Surgical.

STAA stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, Broadfin Capital LLC, Loomis Sayles & Co. L P, UBS Asset Management Americas Inc., Janus Henderson Group PLC, Royce & Associates LP, Bank of America Corp DE and Driehaus Capital Management LLC. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $30.43.

STAAR Surgical has a market capitalization of $1.36 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.

The official website for STAAR Surgical is http://www.staar.com/.

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]